Latest Placement Classifieds,Free Classified Ads,Buy Sell Classified Ads Market Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post